Nesiritide (BNP)
Recombinant B-type natriuretic peptide that helps your heart breathe easier by reducing fluid overload and improving blood flow during acute heart failure crises.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
0.01 mcg/kg/min – 2 mcg/kg
Compound profile
Nesiritide (BNP) scientific & efficacy data
Healing & Recovery
Peptide profile
Strong human trials
Nesiritide (BNP)
2 mcg/kg IV bolus · Once daily
Molecular formula
C143H244N50O42S4
- Mol. weight
- 3464.0 Da
- CAS number
- 114471-18-0
- PubChem
- 71308561
- Developed · 1999
- Scios Research Team
Scios (acquired by Johnson & Johnson)
Amino acid sequence
MDPQTAPSRALLLLLFLHLAFLGGRSHPLGSPGSASDLETSGLQEQRNHLQGKLSELQVEQTSLEPLQESPRPTGVWKSREVATEGIRGHRKMVLYTLRAPRSPKMVQGSGCFGRKMDRISSSSGLGCKVLRRHRapid Symptom Relief
Works quickly: in the VMAC trial, 60% of its 3-hour drop in lung pressure came within 15 minutes of the starting dose, and breathlessness improved more than with placebo at 3 hours [5].
Fluid Management
Lowers the filling pressures that push fluid into the lungs. In VMAC, where diuretics were allowed, the net fluid removed over the first 24 hours (about 1.25 L) was the same as with nitroglycerin [5].
Heart Workload Reduction
Relaxes veins and arteries, lowering the pressures the heart works against: lung wedge pressure, right atrial pressure and pulmonary artery pressure all fell significantly versus placebo at 3 hours in VMAC [5].
Dosing
How much Nesiritide (BNP) do I take?
0.01 mcg/kg/min – 2 mcg/kg
0.01 mcg/kg/min – 2 mcg/kg
Covers all 2 documented dose levels · timing · dose-adjustment guidance.
Every documented dose level
| Phase | Dose | Frequency |
|---|---|---|
| One-time loading dose | 2 mcg/kg IV bolus | Single bolus at initiation |
| Typically up to 48 hours | 0.01 mcg/kg/min continuous infusion | Continuous IV infusion |
Suitability
Is Nesiritide (BNP) right for me?
Best for emergency stabilization of acute heart failure episodes & rapid relief of severe shortness of breath
Best for
Emergency stabilization of acute heart failure episodes
Nesiritide (BNP) is particularly well-suited for individuals focused on emergency stabilization of acute heart failure episodes. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [5].
Rapid relief of severe shortness of breath
Nesiritide (BNP) is particularly well-suited for individuals focused on rapid relief of severe shortness of breath. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [5].
Short-term relief in hospital, not long-term outcome improvement
Nesiritide's benefit is short-term: it lowers lung pressures and eases breathlessness in the first hours of treatment [5]. In the 7,141-patient ASCEND-HF trial it did not reduce 30-day death or heart-failure rehospitalization (9.4% vs 10.1%), and it is not recommended for routine use [2][5].
Managing sudden fluid buildup in the lungs or legs
Nesiritide (BNP) is particularly well-suited for individuals focused on managing sudden fluid buildup in the lungs or legs. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Nesiritide (BNP) with similar peptides to find the best fit for your goals.
Administration
How do I use Nesiritide (BNP)?
Intravenous (IV) bolus · Intravenous (IV) continuous infusion
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is Nesiritide (BNP) safe?
3 common side effects · 2 serious
Nesiritide (Natrecor) was FDA-approved for acutely decompensated heart failure with breathlessness at rest or minimal activity [5].
Low blood pressure is the dose-limiting side effect: 12% of patients versus 4% on placebo in long-infusion trials, and symptomatic hypotension in 7.1% versus 4.0% in the 7,141-patient ASCEND-HF trial [2][5].
When it happens it can last longer than with nitroglycerin (mean 2.2 vs 0.7 hours), because the blood-pressure effect outlasts the drug's 18-minute half-life [5]. Serum creatinine rises more often than with placebo or nitroglycerin, so kidney function is monitored during and after treatment [5].
A pooled analysis of seven trials found no increase in 30- or 180-day mortality, and the trials showed no evidence of tolerance (tachyphylaxis) to its effects [5].
FDA approval rested on the VMAC trial (489 patients), which compared nesiritide with placebo and IV nitroglycerin. At 3 hours nesiritide lowered pulmonary capillary wedge pressure by 5.8 mmHg (vs 2.0 with placebo and 3.8 with nitroglycerin) and improved breathlessness more than placebo [5].
It acts on guanylate cyclase receptors in blood-vessel walls, raising cGMP and widening veins and arteries; in animals it did not change heart contractility [5].
The later ASCEND-HF trial (7,141 patients) found only a small, non-significant improvement in breathlessness and no reduction in 30-day death or heart-failure rehospitalization, and concluded nesiritide cannot be recommended for routine use in acute heart failure [2].
Less common
These typically resolve with continued use or dose adjustment.
Common side effects · experienced by some users
Headache
Headache, reported in 7% of patients versus 6% on placebo during the first 24 hours of infusion [5].
Management: Usually resolves as body adjusts; pain relievers can help if needed
Lightheadedness
Feeling dizzy or faint, typically mild and temporary [5]
Management: Sit or lie down until it passes; inform your medical team if persistent
Back pain
Minor discomfort in the back area during or after treatment [5]
Management: Usually improves on its own; stretching may help
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Nesiritide (BNP)
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Nesiritide (BNP) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:Furosemide — Loop diuretic that enhances fluid removal; nesiritide increases effectiveness by improving kidney blood flow
- Safe:ACE Inhibitors (Lisinopril, Enalapril) — Complements nesiritide's vasodilation; both reduce cardiac workload and improve blood flow
- Safe:Nitroglycerin — Another vasodilator that works synergistically to reduce heart strain and improve perfusion
With medications
- Caution:Excessive diuretics — Combined effect can cause dangerous dehydration and kidney injury; must be carefully monitored
- Caution:Other potent vasodilators in high doses — Risk of dangerously low blood pressure; requires careful dosage adjustment and monitoring
- Caution:Nephrotoxic drugs (NSAIDs, contrast dye) — Nesiritide-related kidney effects may be worsened; avoid if possible during treatment
With supplements
- Safe:Multivitamins — Generally safe to take alongside Nesiritide (BNP). Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know Nesiritide (BNP) is working?
Strong human trials · first signs 0-5 minutes
Evidence level
Strong human trials
(Phase 3 or FDA approved)
Regulatory status
FDA approved for this use
Onset of effects
Moderate
(1-2 weeks)
How it works
Nesiritide is synthetic B-type natriuretic peptide (BNP) that helps failing hearts work better.
It relaxes blood vessels, reduces fluid volume, and helps the heart pump more efficiently—a powerful intervention for acute heart failure.
The deeper mechanism
Nesiritide is recombinant BNP that activates natriuretic peptide receptors, increasing cGMP and causing vasodilation, natriuresis, and reduced aldosterone secretion. Reduces cardiac preload and afterload while improving cardiac output.
What to expect
0-5 minutes
What you might notice
- The medication enters your bloodstream rapidly
- You may feel a slight sensation at the injection site
- Initial bolus injection given
What's normal
- Initial response to Nesiritide (BNP) is beginning at the cellular level
- Different individuals experience Nesiritide (BNP)'s onset at different rates
- Transient systemic effects from initial Nesiritide (BNP) exposure are common
What's next
- Maintain consistent Nesiritide (BNP) administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
5-15 minutes
What you might notice
- You typically notice improvement in breathing difficulty
- Your heart rate and blood pressure begin adjusting
- About 60% of the total 3-hour benefit is usually achieved by this time
- Effects begin
What's normal
- Nesiritide (BNP) is achieving sufficient receptor engagement
- Initial mechanism of Nesiritide (BNP) is taking effect
- Early transient effects from Nesiritide (BNP) administration are resolving
What's next
- Maintain consistent Nesiritide (BNP) administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
15-60 minutes
What you might notice
- Most patients reach 95% of their expected benefit from the medication
- Shortness of breath significantly improves
- Urine production increases noticeably
- Peak relief achieved
What's normal
- Nesiritide (BNP) is achieving sufficient receptor engagement
- Initial mechanism of Nesiritide (BNP) is taking effect
- Early transient effects from Nesiritide (BNP) administration are resolving
What's next
- Maintain consistent Nesiritide (BNP) administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
1-6 hours
What you might notice
- Effects plateau at their maximum level
- Your medical team monitors kidney function and blood pressure continuously
- Most patients feel dramatically better
- Continued symptom improvement
What's normal
- Nesiritide (BNP) is achieving sufficient receptor engagement
- Initial mechanism of Nesiritide (BNP) is taking effect
- Early transient effects from Nesiritide (BNP) administration are resolving
What's next
- Maintain consistent Nesiritide (BNP) administration as prescribed
- Document subjective effects and physical markers daily
- Schedule a check-in with your provider about initial observations
6-24 hours
What you might notice
- Depending on your condition, the IV drip may continue, be adjusted, or be discontinued
- If stopped, effects wear off within 30 minutes due to the short 18-minute half-life
- Infusion continues or stops
What's normal
- Nesiritide (BNP) response patterns are emerging
- Initial Nesiritide (BNP) response is consistent with mechanism expectations
- Early tolerance development to Nesiritide (BNP) is not expected
What's next
- Assess whether Nesiritide (BNP) response aligns with expectations
- Plan next steps based on initial Nesiritide (BNP) tolerance and response
- Establish baseline monitoring for Nesiritide (BNP) response tracking
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to Nesiritide (BNP) over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Questions
Frequently asked about Nesiritide (BNP)
How quickly does nesiritide work?
Nesiritide is one of the fastest-acting heart failure medications. Most patients notice improvement in breathing within 5-15 minutes of receiving the initial bolus dose. About 60% of the medication's effect is usually achieved within 15 minutes, and 95% within one hour. This rapid action makes it ideal for emergency situations.
Can I take nesiritide at home?
No. Nesiritide must be administered intravenously by medical professionals in a hospital, emergency room, or specialized infusion center. It requires continuous monitoring of your heart rate, blood pressure, and kidney function. The medication cannot be given by injection under the skin or taken by mouth.
What happens if nesiritide causes low blood pressure?
Low blood pressure is one of the most common side effects. Your medical team actively monitors this and can adjust the dose, slow the infusion rate, or add extra fluids through an IV to raise your blood pressure back up. In most cases, they can manage this by adjusting the nesiritide dose without stopping it entirely.
Can nesiritide damage my kidneys?
Nesiritide can occasionally cause a temporary decline in kidney function, especially in patients with existing kidney problems. This is why your medical team checks kidney function before, during, and after treatment. The good news is that nesiritide's kidney effects are usually reversible once the medication is stopped. Your doctor will decide if nesiritide is appropriate for you based on your kidney function.
How is nesiritide different from other heart failure medications?
Nesiritide is unique because it's the only medication that's a recombinant copy of your body's natural BNP hormone. It works faster than most oral heart medications and provides relief within minutes rather than days or weeks. However, it only works intravenously in acute settings, whereas drugs like ACE inhibitors can be taken at home long-term. Nesiritide is designed for emergency crisis management, not ongoing maintenance therapy.
Will nesiritide cure my heart failure?
No. Nesiritide provides temporary relief of acute symptoms but doesn't cure heart failure or repair the underlying heart damage. Think of it as a lifeline during a crisis. After the acute episode improves, you'll need to take other long-term medications and make lifestyle changes to manage your heart condition going forward.
How long can I stay on nesiritide?
Nesiritide is designed for short-term acute use, typically during a hospital stay. Most patients receive it for 24-72 hours. It's not appropriate for long-term home use. After stabilization, you'll transition to oral medications and follow-up with your cardiologist.
Further reading
Nesiritide (BNP) history & related research
History · since 1988
The heart's own healing signal, recreated in the lab to help failing hearts.
Nesiritide is an exact copy of a natural protein your heart makes when it is struggling. When your heart fails, your body tries to heal itself by releasing this protein.
Read the full history of Nesiritide (BNP)Studied for
Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Nesiritide (BNP), on one page.